Skip to content

LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System

LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04633603
Enrollment
10000
Registered
2020-11-18
Start date
2020-01-15
Completion date
2028-01-15
Last updated
2024-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Bacterial Infections, Fever, Help-Seeking Behavior, Overdose of Analgesic Drug, Virus Diseases

Keywords

childhood fever, help-seeking behavior, fever phobia, mobile application, guideline adherence, antipyretics, antibiotics, health literacy, socio-economic assessment

Brief summary

The positive effects of fever are supported by a number of physiological, pathophysiological and clinical evidence. However, the negative attitude toward fever is widespread and have become persistent. According to sociological research, this is based on two main factors: comfort and fear. To change this negative attitude, awareness needs to be raised and the attitude toward fever among health care workers and the lay public needs to be reframed positively. Furthermore, the role of media users is essential, especially among the young generation. The current Hungarian recommendation/protocol is valid since 2011 (Professional protocol of the Ministry of National Resources: Caring for a child with fever, the recommendation of the College of Pediatric and Pediatric However, the practical implementation among health professionals and the laity public is low. Based on this protocol and current international guidelines (NICE) clinicians developed a protocol and register, where parents and caregivers can document the symptoms and runoff of fever as well as receive feedback on severity and appropriate management. The project aims to increase the evidence-based (EBM) guideline adherence, to reduce the unnecessary use of antipyretics and antibiotics, as well as the load on the current healthcare system. The documentation of the collected data allows the investigators to map and analyze (stats) socio-demographic behavior both on individual and societal level.

Detailed description

Goal: Reframing the negative attitude toward fever. Reducing unnecessary use of drugs (antipyretics and antibiotics) as well as lower the number of medical consultations. In order, the investigators will use a media-based mobile application and a web knowledge base. Languages English and Hungarian. Hypotheses: 1. The mobile application and knowledge base increases health literacy of parents and professionals. 2. The application will change the uncertain and/or negative attitude toward fever. 3. The positive change in attitude will influence antipyretic and consecutive antibiotic use, lower medical provider contact, enhancing the practical implementation of guidelines. Method: Noninvasive, noninterventional, self-reported, observational, prospective cohort study under real-life conditions. Data: provided by caregivers and/or patients are grouped and classified based on the severity of the disease behind the fever. Data analysis: Analysis sample size calculation: To analyze guideline-adherent and non-adherent behavior at a 95% binomial confidence interval with an accuracy of +/- 2%, at least 500 fever phases are required if the smaller group comprises 5%. The investigators a-priory estimation based on surveys is that only about 15% of caretakers have a guideline-conforming approach to the management of fever, hence 1,500 fever events are needed for the planned accuracy. If adherent and non-adherent groups are approximately the same size, a maximum of ca. 2,500 fever phases are required. The exact incidence of fever per age group is not yet known. Larger samples are required - and expected - for subgroup analyses (e.g. between age groups). Recruitment will therefore continue throughout to year 3 and beyond. The Chi² test is used to compare two subgroups. Sample size planning cannot take unplanned multiple testing into account, so the results can only be interpreted exploratively. Subsample calculations: If a difference of 5% between two frequencies is interpreted as clinically significant, at a power of 80% and an alpha error probability of 5% assuming normal distribution in both subsamples, the following sample sizes are required: For a very rare sample, ca. 200 cases per subsample are sufficient. If the rate is around 50%, ca. 1,600 cases per subsample are required. Software: IBM SPSS Statistics 22, Microsoft Excel ... Research partners providing theoretical and professional background: University of Pécs Hungarian Medical Chamber (Győr-Moson-Sopron Megye) University of Witten Heim Pál Childrens Hospital National Emergency Service Healthware Tanácsadó Kft. Dr. Szőke Henrik és Társa Egészségügyi Szolgáltató Kft. Organizational tasks are conducted in the framework of the University of Pécs, Faculty of Health Sciences and by the Civil Support Közhasznú Nonprofit Kft.

Interventions

DEVICEFeverFriend mobile application

Registration, documentation of patients profile, documentation of fever events, following advice regarding the patient and the care-giver, documentation of follow up notifications.

Sponsors

Dr. Szőke Henrik és Társa Egészségügyi Szolgáltató Kft.
CollaboratorUNKNOWN
Hungarian Medical Chamber / Magyar Orvosi Kamara (Győr-Moson-Sopron Megye)
CollaboratorUNKNOWN
University of Witten
CollaboratorUNKNOWN
Heim Pál Children's Hospital / Heim Pál Országos Gyermekgyógyászati Intézet
CollaboratorUNKNOWN
Hungarian Emergency Service / Országos Mentőszolgálat
CollaboratorUNKNOWN
Civil Support Közhasznú Nonprofit Kft.
CollaboratorUNKNOWN
University of Pecs
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 100 Years
Healthy volunteers
Yes

Inclusion criteria

for patients: 0-100 years age, home or ambulant care, accepting the legal notice (including study-protocol, privacy- and data management), documenting patients profile. Eligibility for documentation of separate fever events: recording at least temperature and measurement method (device and place).

Exclusion criteria

severe underlying disease, patient who needs hospitalization.

Design outcomes

Primary

MeasureTime frameDescription
Action taken, evaluation 448 hours after last fever event documentationUtility of the device and knowledge base (subjective scale 1-2-3-4-5; minimum 1 = worst; maximum 5 = best)
Fever events outcome, condition of the patient 15During the period of single fever event (up to 5 days)wry neck yes - no
Fever events outcome, condition of the patient 16During the period of single fever event (up to 5 days)pain yes - no pain location local - general duration hours
Care-givers state 1During the period of fever event (up to 5 days)Care-givers own feeling about the progress of patients illness (subjective scale,1 best = optimal - 2 = not sure - 3 = worst = very worried)
Care-givers state 2During the period of fever event (up to 5 days)Care-givers personal opinion about patients state: (subjective scale: minimum = best = not severe, middle = somewhat severe, maximum = worst = very severe)
Care-givers state 3During the period of fever event (up to 5 days)Care-givers self-confidence in handling the situation (subjective scale: maximum = confident; worse = somewhat confident, even worse = not really, minimum = worst = not at all)
Action taken, evaluation 148 hours after illness resolvingUse of medication, use of medical providers service, utility of the device and knowledge base
Action taken, evaluation 248 hours after illness resolvingUse of medication no - yes (type and dosage)
Action taken, evaluation 348 hours after last fever event documentationUse of medical providers service no - yes (institution type)
Fever events outcome, condition of the patient 1During the period of single fever event (up to 5 days)body temperature grade Celsius
Fever events outcome, condition of the patient 2During the period of single fever event (up to 5 days)duration of fever in days
Fever events outcome, condition of the patient 3Before and during the period of single fever event (up to 20 days)medication, vaccination type and dosage
Fever events outcome, condition of the patient 4During the period of single fever event (up to 5 days)hydration: normal - somewhat decreased - severely decreased
Fever events outcome, condition of the patient 5During the period of single fever event (up to 5 days)ventilation: rate per minute
Fever events outcome, condition of the patient 6During the period of single fever event (up to 5 days)ventilation: wheezing and dyspnea (subjective scale 1-2-3-4-5; minimum 1; maximum 5; 1 is no symptom = better, 5 is the worst)
Fever events outcome, condition of the patient 7During the period of single fever event (up to 5 days)skin condition: color and rash
Fever events outcome, condition of the patient 8During the period of single fever event (up to 5 days)pulse rate beat per minute
Fever events outcome, condition of the patient 9During the period of single fever event (up to 5 days)crying quality (no, normal, abnormal)
Fever events outcome, condition of the patient 10During the period of single fever event (up to 5 days)eating last time in hours
Fever events outcome, condition of the patient 11During the period of single fever event (up to 5 days)urination painful or smelly (yes - no)
Fever events outcome, condition of the patient 12During the period of single fever event (up to 5 days)awareness: normal - sleepy - no (subjective scale; minimum = best = normal; maximum = worst = no)
Fever events outcome, condition of the patient 13During the period of single fever event (up to 5 days)exotic trip in the last 12 month yes - no
Fever events outcome, condition of the patient 14During the period of single fever event (up to 5 days)seizure yes - no

Other

MeasureTime frameDescription
Baseline characteristics (profile of patient) 2at registry on the first daygender: male - female - other
Baseline characteristics (profile) 3at registry on the first dayheight centimeter
Baseline characteristics (profile) 4at registry on the first dayweight kilogram
Baseline characteristics (profile) 5at registry on the first daychronic disease yes - no
Baseline characteristics (profile) 6at registry on the first dayFormer use of medication in the last 12 month (antipyretics, antibiotics) yes - no, number
Baseline characteristics (profile) 7at registry on the first dayFormer use of healthcare providers service in the last 12 month no - yes, number of events and type of institution
Baseline characteristics (profile) 8at registry on the first dayCaregivers former state at fever events of the patient in the last 12 month: care-givers state of mind, level of anxiety, behavior (subjective scale 1-2-3-4; )
Baseline characteristics (profile of patient) 1at registry on the first daydate of birth

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026